EichorEICHOR
Study identifier: NCT04487639 Synced from ClinicalTrials.gov · August 04, 2026
● Completed

Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ?

Condition: Sperm Preservation in Oncological Patients · Fertility · Cryopreservation  ·  Sponsor: University Hospital, Clermont-Ferrand

PhaseNA
Planned participants129
Who can joinMale, 18 Years to 60 Years
Healthy volunteersNo

About this study

During the COVID-19 pandemic, the French Agency of Biomedicine has recommended maintaining fertility preservation for patients requiring immediate oncological treatments exhibiting gonadotoxic effects. However, no study has examined the presence of SARS-CoV-2 in sperm from cancer patients. This study aims therefore to detect the presence of SARS-CoV-2, specifically in the seminal fluid and the spermatozoa fractions of cancer patient semen. The investigators will determine if the virus presence in sperm is associated with its presence in the nasal swabs, COVID symptoms, specific serological profiles and particular oncological pathologies/treatments.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (16)

AP-Hôpitaux de Paris - Hôpital Jean Verdier - Service de Biologie de la reproductionBondy, France, France
AP-Hôpitaux de Paris - Hôpital Antoine Béclére - Service de Biologie de la reproduction et AMP DPI CECOSClamart, France, France
CHU de Clermont-Ferrand - Laboratoire de VirologieClermont-Ferrand, France, France
CHU de Clermont-FerrandClermont-Ferrand, France, France
CHU de Dijon - Laboratoire de Biologie de la Reproduction-CECOSDijon, France, France
CHU de Grenoble - Laboratoire d'Aide à la Procréation CECOSGrenoble, France, France
Hospices Civils de Lyon - Service AMP-CECOSLyon, France, France
Hôpital de la Conception - AP-Hôpitaux de Marseille - Service AMP-CECOSMarseille, France, France
CHU de Nancy - Laboratoire de biologie de la reproduction - CECOSNancy, France, France
AP-Hôpitaux de Paris - Hôpital Tenon - Service de Biologie de la reproduction - CECOSParis, France, France
AP-Hôpitaux de Paris - Hôpital Cochin - Service d'Histologie-Embryologie-Biologie de la reproductionParis, France, France
Centre Hospitalier intercommunal (CHI) de Poissy Saint Germain en LayePoissy, France, France

+ 4 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →